This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Actinic Keratosis Treatment Market

Market Insights on Actinic Keratosis Treatment covering sales outlook, demand forecast & up-to-date key trends

Actinic Keratosis Treatment Market by Treatment Type (Topical Treatment, Procedural Modality, Photodynamic Therapy and Others), Disease Type (Clinical AK and Subclinical AK) & Region - Forecast 2022-2028

Actinic Keratosis Treatment Market Snapshot

[275 Pages Report] The global Actinic Keratosis Treatment Market was valued at US$ 5.0 Bn in 2021 and is expected to reach US$ 8.0 Bn by 2028, finds Future Market Insights (FMI) in a recent market survey.

Data Points

Market Insights

Market Value 2022

USD 5.4 Bn

Market Value 2028

USD 8.0 Bn

CAGR 2022-2028

7.0%

Key Players

The key players are Sun Pharmaceutical Industries Ltd., Biofrontera, Nestle SA, Bausch Health Companies Inc., Novartis AG, GlaxoSmithKline plc., Almirall, LLC, LEO Pharma Inc., Cipher Pharmaceuticals Inc. and Pierre Fabre Pharmaceuticals, Inc.

Share of Top 5 Countries           

61.3%

Growing prevalence of actinic keratosis, increase in need for actinic keratosis treatment products, potential drugs in pipeline, and preferable use of topical therapeutics are the primary factors fueling the development of the actinic keratosis treatment market. In addition, the growing incidences of skin cancer, together with the increasing demand for minimally invasive surgeries, is supporting the actinic keratosis treatment market growth.

Also, together with considerable investment in research and development (R&D) activities to manufacture novel therapies with convenient dosage, improved efficacy, and reduced costs, is creating favorable opportunities for the players in the actinic keratosis treatment market.

Actinic Keratosis Treatment market holds nearly 16.6% market value share of the US$ 30 Bn Dermatology Market in 2021. The surgical procedure is expected to be the most preferred for actinic keratosis due to availability of minimally invasive surgeries.

Moreover, new product launches are projected to increase in the forthcoming years as huge number of products are in pipeline for approval for treatment of actinic keratosis.

For instance, in June 2020, Sun Pharmaceutical Industries Ltd. launched Levulan Kerastick, a topical solution for the treatment of mild to moderate actinic keratosis of the scalp, face, and upper extremities

Driven by this, sales of actinic keratosis treatments are expected to rise at a 7.0% CAGR through 2028.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

7.02%

H1, 2022 Projected

6.89%

H1, 2022 Outlook

6.79%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 23 ↓

A comparative analysis related to the market growth rates and development prospects in the global actinic keratosis treatment market is presented by Future Market Insights.  The market is highly influenced by the regulatory approvals and innovation factors under the impact of macro and industry factors.

The market is subject to developments like, acquisitions and collaborations, wherein the collaborations are mainly done to expand the skin and cosmetic product portfolio.

According to Future Market Insight analysis, the global actinic keratosis treatment market expects to drop by 23 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 Projected value, the market during H1-2022 outlook period will show a dip of 10 BPS.

The advent of the COVID-19 pandemic imposed restrictions upon the general population to be rendered indoors. Owing to this, the lowered exposure to sun has led to a reduction in the occurrence of actinic keratosis, with online distribution channels flourishing as means of proliferation of essential goods.

In developing regions, dearth of skilled professionals and lower treatment adoption rate contribute in negatively impacting the market growth. The lack of awareness in developing regions as well as traditional treatment methods like application of apple cider vinegar can further hamper the market growth.  

The actinic keratosis market has the potential to grow during the coming years owing to increasing research & development (R&D) activities to fast track the new drug approvals for the actinic keratosis treatment. Also, the increased risk of developing actinic keratosis associated skin cancer has led to rise in diagnosis & treatment rate.

2013-2021 Actinic Keratosis Treatment Market Demand Outlook Compared to 2022-2028 Forecast

Sales of actinic keratosis treatment grew at a CAGR of 6.6% between 2013 and 2021.

Rising prevalence of actinic keratosis together with rising awareness regarding treatment of the disease and growing adoption of minimally invasive treatments is expected to boost the demand for the actinic keratosis treatment market.

Increasing awareness regarding the adverse effect of actinic keratosis is driving the demand for actinic keratosis treatment. Moreover, awareness campaigns being conducted by government agencies and non-profit organizations is adding considerably to the market development.

Actinic Keratosis Treatment Market Download Report Brochure

For instance, a campaign was launched in 2019 by the Skin Cancer Foundation titled, “Ray Awareness – Preventing Skin Cancer” to boost awareness regarding the tanning beds on the skin as an effect of exposure to UV radiations from the sun while emphasizing actinic keratosis treatment as a primary measure in order to prevent non-melanoma cancer.

The increasing research & development (R&D) activities are anticipated to surge the new drug approvals for the actinic keratosis treatment over the forecast period. Also, the increased risk of developing actinic keratosis associated skin cancer has led to rise in diagnosis & treatment rate.

Considering this, FMI expects the global actinic keratosis treatment market to grow at a CAGR of 7.0% through 2028.

Which Factors Are Restraining Demand for Actinic Keratosis Treatment?

The lack of skilled professionals and low penetration of treatment in developing markets are the major factors hindering the growth of the actinic keratosis treatment market.

Skilled professionals and surgeons are needed for performing actinic keratosis treatment such as chemical peel, cryotherapy, and photodynamic therapy. But, a considerable shortage in the amount of general surgeons is projected to hamper actinic keratosis market development. As per the recent WHO study, there is expected a shortage of around 13 million healthcare professionals across the world by the end of 2035.

In addition, less awareness regarding the health condition in emerging nations and higher treatment costs are expected to restrain growth of the market. Availability of alternative natural treatments is also anticipated to hamper the market growth.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Impact of the COVID-19 Crisis on the Actinic Keratosis Treatment Market?

The coronavirus is continuously marching across the world, disrupting almost all businesses worldwide. This pandemic outbreak affected industries and several economies because of travel bans, lockdowns, and business closures.

As a consequence of pandemic related lockdowns in several nations and disturbances in the supply chain of medical equipment, the actinic keratosis treatment market observed a drop in sales in 2020.

In 2020, the detection and treatment rates have been decreased considerably because of the limitations on non-essential doctor visits and strict lockdown in many countries. For example, in 2020, about 12.7 million treatments such as topical drugs, photodynamic therapy, and surgical for actinic keratosis were carried out in the U.S. while, in 2019, there were about 15.1 million treatments performed for actinic keratosis.

Country-wise Insights

What Makes the U.S. a Large Market for Actinic Keratosis Treatment?

The U.S. is estimated to account for around 91.5% of the North America Actinic Keratosis Treatment market in 2022.  

High prevalence of disease, proactive government measures, rising consumer awareness, and technological advancements are factors contributing to the growth of the market in U.S. As per the American Academy of Dermatology Association, over 40 million Americans suffer from actinic keratosis (AKs) every year. In addition, the availability of well-developed healthcare infrastructure and growing healthcare spending is expected to lead to increase in demand for actinic keratosis treatment in U.S.

Why is U.K. Considered a Lucrative Actinic Keratosis Treatment Market?

U.K. is estimated to account for 27.0% of the Europe actinic keratosis treatment market in Europe in 2022.

The development of the market in U.K. is owing to the high prevalence of actinic keratosis and growing adoption of minimally invasive procedures. In addition, minimally invasive surgeries are first line of treatment for most of the actinic keratosis. Low cost treatment for actinic keratosis together with favorable reimbursements by Medicaid and Medicare are some of the other factors anticipated to boost the demand for the actinic keratosis treatment market and drive the development of the market.

What are the Factors Fueling the Demand for Actinic Keratosis Treatment in Japan?

The actinic keratosis treatment market in Japan is estimated to be worth US$ 145.7 Mn in 2022 in the global market.

Strong reimbursement policies in Japan and large population base over age 40 years are some of the major factors responsible for the growth of the market in Japan. Moreover, high adoption of combination therapies such as topical and cryotherapy are expected to propel the growth of Japan actinic keratosis treatment market.

Actinic keratosis could be eliminated by freezing them together with liquid nitrogen. When the substance is applied, the skin starts healing, as the skin heals, the damaged cells get removed, permitting new skin to appear. Cryotherapy is the most common treatment. Moreover, increasing dermatology visits as growing awareness regarding skin disorder are expected to propel the growth of Japan actinic keratosis market.

How will the Actinic Keratosis Treatment Market Expand across India?

Demand for actinic keratosis treatment in India is expected to rise at around 7.7% CAGR over the forecast period.

The growing patient pool affected from actinic keratosis, increasing per capita healthcare expenditure and increasing R&D funding for novel therapies is expected to be the primary factors fueling the development of the actinic keratosis treatment market in India. Moreover, rising geriatric population India that is highly prone to actinic keratosis is one of the major factors driving the market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Demand for Topical Treatment to continue gaining Traction

By treatment type, topical treatment is anticipated to hold the maximum share of 46.9% in 2022, expanding at rate of nearly 6.2% during the forecast period.

Growing adoption of self-administered treatment and easy availability of home-based therapy options is expected to drive the growth of the segment. Topical creams comprising fluorouracil that is a chemotherapy drug, and other medicines such as Imiquimod (INN) gels and diclofenac which is an analgesic, are mostly prescribed as topical treatment for actinic keratosis. The combined treatment of cryotherapy and fluorouracil with the help of cryosurgery units is also adopted due to its great success rate in treatment of actinic keratosis.

Why Clinical Actinic Keratosis will hold the most of the market share?

By disease type, clinical actinic keratosis will lead the market and is projected to account for 95.2% of the total market revenue share in 2022.

The growing prevalence of clinical actinic keratosis is the primary factor driving the segment growth. While the occurrence of actinic keratosis is growing, awareness regarding the risk of disease leading to the development of a cancer is convincing dermatologists for more clinical diagnosis. Rising awareness regarding the risk of clinical actinic keratosis lesions is expected to add to the development of the segment over the forecast period.

Why Hospitals projected maximum growth in the Actinic Keratosis Treatment Market?

By end user, the hospitals segment is anticipated to hold the maximum share of 34.0% in 2022, expanding at rapid rate of 6.4% CAGR during the forecast period.

The ease of accessibility of patient pool in hospitals owing to the availability of required therapies and medications at a single place is a primary factor adding towards the highest share of the segment. In addition, developing healthcare infrastructure, high adoption of surgical procedures and growing adoption of photodynamic therapy is expected to drive the growth of the actinic keratosis treatment market.

Competitive Landscape

Companies operating in the actinic keratosis treatment market are consolidated and competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:

  • In December 2020, Almirall, S.A. received the U.S. FDA approval for Klisyri (tirbanibulin) for the treatment of actinic keratosis of the face and scalp.
  • In April 2020, Biofrontera signed an exclusive agreement with Maruho Co., Ltd. in Japan for the development and commercialization of Ameluz, medicine used in adults to treat mild to moderate actinic keratosis in the Asia Pacific region.

Scope Of The Report

Attribute

Details

Forecast Period

2013-2021

Historical Data Available for

2022-2028

Market Analysis

USD Million for Value

Key Countries Covered

US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa

Key Segments Covered

Treatment Type, Disease Type, End User and Region

Key Companies Profiled

  • Sun Pharmaceutical Industries Ltd.
  • Biofrontera
  • Nestle SA
  • Bausch Health Companies Inc.
  • Novartis AG
  • GlaxoSmithKline plc.
  • Almirall, LLC
  • LEO Pharma Inc.
  • Cipher Pharmaceuticals Inc.
  • Pierre Fabre Pharmaceuticals, Inc.

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Actinic Keratosis Treatment Market By Category

By Treatment Type:

  • Topical Treatment
    • 5-fluorouracil Cream
    • Diclofenac Gel
    • Imiquimod Cream
    • Ingenol mebutate Gel
  • Procedural Modality
    • Chemical Peels
    • Cryotherapy
  • Photodynamic Therapy
  • Others

By Disease Type:

  • Clinical AK
  • Subclinical AK

By End User:

  • Hospitals
  • Private Dermatology Clinics
  • Laser Therapy Centers
  • Cancer Treatment Centers
  • Spas and Rejuvenation Centers
  • Homecare

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Frequently Asked Questions

The global actinic keratosis treatment market is worth US$ 5.0 Bn in 2021 and is set to expand 1.5X over the forecasted years owing to the rising adoption of minimally invasive therapy and growing cases of actinic keratosis.

The sales of actinic keratosis treatment in the market have grown at a CAGR of nearly 6.6% between 2013 and 2021.

The actinic keratosis treatment market is expected to reach US$ 8.0 Bn by the end of 2028 with sales revenue expected to register CAGR of 7.0% over the forecast period.

North America currently holds the largest market share in the actinic keratosis treatment. North America currently holds 44.8% in 2022 of the global market share in actinic keratosis treatment market with U.S. being the leading contributor with a market value over US$ 2.2 Bn in 2022.

Demand of actinic keratosis treatment market is expected to register growth in Western Europe at rate of 6.8% CAGR during the forecast period.

The actinic keratosis treatment in Japan is likely to observe growth with an impressive CAGR of 6.3% during the forecast period.

Acquisition strategy by leading manufacturers, increasing use of topical fluorouracil and cryotherapy for actinic keratosis treatment, companies emphasizing on collaborations and product innovation are key trends driving sales of actinic keratosis treatment market across the globe.

China’s actinic keratosis treatment market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 7.8% CAGR during the forecast period. India actinic keratosis treatment market is expected to exhibit healthy growth of 7.7% CAGR during the forecast period.

U.S., U.K., Germany, China and France are the top 5 countries that are driving the demand for actinic keratosis treatment market.

Leading companies of actinic keratosis treatment are Sun Pharmaceutical Industries Ltd., Biofrontera, Nestle SA, Bausch Health Companies Inc., Novartis AG, GlaxoSmithKline plc, Almirall, LLC, LEO Pharma Inc., Cipher Pharmaceuticals Inc. and Pierre Fabre Pharmaceuticals, Inc.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Exclusion and Inclusion

3. Global Economic Outlook

    3.1. Gross Domestic Product by Region & Country, 2006 – 2021

    3.2. Global Healthcare Market Indicators

4. Market Opportunity Analysis

    4.1. Macro-Economic Factors

    4.2. Opportunity Analysis

5. Market Dynamics

    5.1. Drivers

        5.1.1. Supply Side Drivers

        5.1.2. Demand Side Drivers

    5.2. Restraints

    5.3. Trends

6. Market Data Call Out

    6.1. Parent Market Analysis

    6.2. Disease Epidemiology

    6.3. Treatment Regimen

    6.4. Procedure Volume of Cosmetic Therapies

    6.5. Key Regulations

    6.6. Reimbursement Scenario and Payer Mix Analysis

    6.7. Treatment Cost by Region

7. North America Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        7.2.1. U.S.

        7.2.2. Canada

    7.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    7.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021

        7.4.1. Topical Treatment

            7.4.1.1. 5-fluorouracil Cream

            7.4.1.2. Diclofenac Gel

            7.4.1.3. Imiquimod Cream

            7.4.1.4. Ingenol mebutate Gel

        7.4.2. Procedural Modality

            7.4.2.1. Chemical Peels

            7.4.2.2. Cryotherapy

        7.4.3. Photodynamic Therapy

        7.4.4. Others

    7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    7.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021

        7.6.1. Clinical AK

        7.6.2. Subclinical AK

    7.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028

    7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

        7.8.1. Hospitals

        7.8.2. Private Dermatology Clinics

        7.8.3. Laser Therapy Centers

        7.8.4. Cancer Treatment Centers

        7.8.5. Spas and Rejuvenation Centers

        7.8.6. Homecare

    7.9. Market Size (US$ Mn) Forecast By End User, 2022–2028

    7.10. Market Attractiveness Analysis

        7.10.1. By Country

        7.10.2. By Treatment Type

        7.10.3. By Disease Type

        7.10.4. By End User

    7.11. Drivers and Restraints: Impact Analysis

    7.12. Key Market Participants – Intensity Mapping

8. Latin America Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    8.1. Introduction

    8.2. Regional Market Trends

    8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        8.3.1. Brazil

        8.3.2. Mexico

        8.3.3. Rest of Latin America

    8.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

    8.5. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021

        8.5.1. Topical Treatment

            8.5.1.1. 5-fluorouracil Cream

            8.5.1.2. Diclofenac Gel

            8.5.1.3. Imiquimod Cream

            8.5.1.4. Ingenol mebutate Gel

        8.5.2. Procedural Modality

            8.5.2.1. Chemical Peels

            8.5.2.2. Cryotherapy

        8.5.3. Photodynamic Therapy

        8.5.4. Others

    8.6. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    8.7. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021

        8.7.1. Clinical AK

        8.7.2. Subclinical AK

    8.8. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028

    8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

        8.9.1. Hospitals

        8.9.2. Private Dermatology Clinics

        8.9.3. Laser Therapy Centers

        8.9.4. Cancer Treatment Centers

        8.9.5. Spas and Rejuvenation Centers

        8.9.6. Homecare

    8.10. Market Size (US$ Mn) Forecast By End User, 2022–2028

    8.11. Market Attractiveness Analysis

        8.11.1. By Country

        8.11.2. By Treatment Type

        8.11.3. By Disease Type

        8.11.4. By End User

    8.12. Drivers and Restraints: Impact Analysis

    8.13. Key Market Participants – Intensity Mapping

9. Western Europe Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        9.2.1. Germany

        9.2.2. U.K

        9.2.3. France

        9.2.4. Italy

        9.2.5. Spain

        9.2.6. Rest of Western Europe

    9.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021

        9.4.1. Topical Treatment

            9.4.1.1. 5-fluorouracil Cream

            9.4.1.2. Diclofenac Gel

            9.4.1.3. Imiquimod Cream

            9.4.1.4. Ingenol mebutate Gel

        9.4.2. Procedural Modality

            9.4.2.1. Chemical Peels

            9.4.2.2. Cryotherapy

        9.4.3. Photodynamic Therapy

        9.4.4. Others

    9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021

        9.6.1. Clinical AK

        9.6.2. Subclinical AK

    9.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028

    9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

        9.8.1. Hospitals

        9.8.2. Private Dermatology Clinics

        9.8.3. Laser Therapy Centers

        9.8.4. Cancer Treatment Centers

        9.8.5. Spas and Rejuvenation Centers

        9.8.6. Homecare

    9.9. Market Size (US$ Mn) Forecast By End User, 2022–2028

    9.10. Market Attractiveness Analysis

        9.10.1. By Country

        9.10.2. By Treatment Type

        9.10.3. By Disease Type

        9.10.4. By End User

    9.11. Drivers and Restraints: Impact Analysis

    9.12. Key Market Participants – Intensity Mapping

10. Eastern Europe Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        10.2.1. Russia

        10.2.2. Poland

        10.2.3. Rest of Eastern Europe

    10.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021

        10.4.1. Topical Treatment

            10.4.1.1. 5-fluorouracil Cream

            10.4.1.2. Diclofenac Gel

            10.4.1.3. Imiquimod Cream

            10.4.1.4. Ingenol mebutate Gel

        10.4.2. Procedural Modality

            10.4.2.1. Chemical Peels

            10.4.2.2. Cryotherapy

        10.4.3. Photodynamic Therapy

        10.4.4. Others

    10.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021

        10.6.1. Clinical AK

        10.6.2. Subclinical AK

    10.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028

    10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

        10.8.1. Hospitals

        10.8.2. Private Dermatology Clinics

        10.8.3. Laser Therapy Centers

        10.8.4. Cancer Treatment Centers

        10.8.5. Spas and Rejuvenation Centers

        10.8.6. Homecare

    10.9. Market Size (US$ Mn) Forecast By End User, 2022–2028

    10.10. Market Attractiveness Analysis

        10.10.1. By Country

        10.10.2. By Treatment Type

        10.10.3. By Disease Type

        10.10.4. By End User

    10.11. Drivers and Restraints: Impact Analysis

    10.12. Key Market Participants – Intensity Mapping

11. Asia Pacific Excluding Japan Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        11.2.1. India

        11.2.2. Australia and New Zealand

        11.2.3. China

        11.2.4. ASEAN

        11.2.5. Rest of APECJ

    11.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021

        11.4.1. Topical Treatment

            11.4.1.1. 5-fluorouracil Cream

            11.4.1.2. Diclofenac Gel

            11.4.1.3. Imiquimod Cream

            11.4.1.4. Ingenol mebutate Gel

        11.4.2. Procedural Modality

            11.4.2.1. Chemical Peels

            11.4.2.2. Cryotherapy

        11.4.3. Photodynamic Therapy

        11.4.4. Others

    11.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    11.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021

        11.6.1. Clinical AK

        11.6.2. Subclinical AK

    11.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028

    11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

        11.8.1. Hospitals

        11.8.2. Private Dermatology Clinics

        11.8.3. Laser Therapy Centers

        11.8.4. Cancer Treatment Centers

        11.8.5. Spas and Rejuvenation Centers

        11.8.6. Homecare

    11.9. Market Size (US$ Mn) Forecast By End User, 2022–2028

    11.10. Market Attractiveness Analysis

        11.10.1. By Country

        11.10.2. By Treatment Type

        11.10.3. By Disease Type

        11.10.4. By End User

    11.11. Drivers and Restraints: Impact Analysis

    11.12. Key Market Participants – Intensity Mapping

12. Japan Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021

        12.2.1. Topical Treatment

            12.2.1.1. 5-fluorouracil Cream

            12.2.1.2. Diclofenac Gel

            12.2.1.3. Imiquimod Cream

            12.2.1.4. Ingenol mebutate Gel

        12.2.2. Procedural Modality

            12.2.2.1. Chemical Peels

            12.2.2.2. Cryotherapy

        12.2.3. Photodynamic Therapy

        12.2.4. Others

    12.3. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    12.4. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021

        12.4.1. Clinical AK

        12.4.2. Subclinical AK

    12.5. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028

    12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

        12.6.1. Hospitals

        12.6.2. Private Dermatology Clinics

        12.6.3. Laser Therapy Centers

        12.6.4. Cancer Treatment Centers

        12.6.5. Spas and Rejuvenation Centers

        12.6.6. Homecare

    12.7. Market Size (US$ Mn) Forecast By End User, 2022–2028

    12.8. Market Attractiveness Analysis

        12.8.1. By Country

        12.8.2. By Treatment Type

        12.8.3. By Disease Type

        12.8.4. By End User

    12.9. Drivers and Restraints: Impact Analysis

    12.10. Key Market Participants – Intensity Mapping

13. Middle East and Africa Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        13.2.1. GCC Countries

        13.2.2. South Africa

        13.2.3. Rest of Middle East and Africa

    13.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    13.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021

        13.4.1. Topical Treatment

            13.4.1.1. 5-fluorouracil Cream

            13.4.1.2. Diclofenac Gel

            13.4.1.3. Imiquimod Cream

            13.4.1.4. Ingenol mebutate Gel

        13.4.2. Procedural Modality

            13.4.2.1. Chemical Peels

            13.4.2.2. Cryotherapy

        13.4.3. Photodynamic Therapy

        13.4.4. Others

    13.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    13.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021

        13.6.1. Clinical AK

        13.6.2. Subclinical AK

    13.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028

    13.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021

        13.8.1. Hospitals

        13.8.2. Private Dermatology Clinics

        13.8.3. Laser Therapy Centers

        13.8.4. Cancer Treatment Centers

        13.8.5. Spas and Rejuvenation Centers

        13.8.6. Homecare

    13.9. Market Size (US$ Mn) Forecast By End User, 2022–2028

    13.10. Market Attractiveness Analysis

        13.10.1. By Country

        13.10.2. By Treatment Type

        13.10.3. By Disease Type

        13.10.4. By End User

    13.11. Drivers and Restraints: Impact Analysis

    13.12. Key Market Participants – Intensity Mapping

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis

    16.1. Market Structure by Tier

    16.2. Brand Share Analysis (2021) for Photodynamic Therapy

    16.3. Product Intensity Mapping by Manufacturer

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competitors Deep Dive

        17.2.1. Sun Pharmaceutical Industries Ltd.

        17.2.2. Biofrontera

        17.2.3. Nestle SA

        17.2.4. Bausch Health Companies Inc.

        17.2.5. Novartis AG

        17.2.6. GlaxoSmithKline plc.

        17.2.7. Almirall, LLC

        17.2.8. LEO Pharma Inc.

        17.2.9. Cipher Pharmaceuticals Inc

        17.2.10. Pierre Fabre Pharmaceuticals, Inc.

18. Global Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028 By Region

    18.1. Introduction / Key Findings

    18.2. Historical Market Size (US$ Mn) Analysis By Region

        18.2.1. North America

        18.2.2. Latin America

        18.2.3. Western Europe

        18.2.4. Eastern Europe

        18.2.5. Asia Pacific Excluding Japan

        18.2.6. Japan

        18.2.7. Middle East and Africa

    18.3. Market Size (US$ Mn) Forecast By Region

    18.4. Market Attractiveness Analysis By Region

19. Global Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

    19.1. Introduction/Key Finding

    19.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2021

        19.2.1. Topical Treatment

            19.2.1.1. 5-fluorouracil Cream

            19.2.1.2. Diclofenac Gel

            19.2.1.3. Imiquimod Cream

            19.2.1.4. Ingenol mebutate Gel

        19.2.2. Procedural Modality

            19.2.2.1. Chemical Peels

            19.2.2.2. Cryotherapy

        19.2.3. Photodynamic Therapy

        19.2.4. Others

    19.3. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028

    19.4. Market Attractiveness Analysis By Treatment Type

20. Global Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028, By End User

    20.1. Introduction/Key Finding

    20.2. Historical Market Size (US$ Mn) Analysis By End User, 2013–2021

        20.2.1. Clinical AK

        20.2.2. Subclinical AK

    20.3. Market Size (US$ Mn) Forecast By End User, 2022–2028

    20.4. Market Attractiveness Analysis By End User

21. Global Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028, By End User

    21.1. Introduction/Key Finding

    21.2. Historical Market Size (US$ Mn) Analysis By End User, 2013–2021

        21.2.1. Hospitals

        21.2.2. Private Dermatology Clinics

        21.2.3. Laser Therapy Centers

        21.2.4. Cancer Treatment Centers

        21.2.5. Spas and Rejuvenation Centers

        21.2.6. Homecare

    21.3. Market Size (US$ Mn) Forecast By End User, 2022–2028

    21.4. Market Attractiveness Analysis By End User

22. Global Actinic Keratosis Treatment Market  Analysis 2013–2021 and Forecast 2022–2028

    22.1. Market Value Analysis (US$ Mn)

    22.2. Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 – 2021 (1/2)

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 – 2021 (2/2)

Table 03: Prescription Pattern for Actinic Keratosis Treatment

Table 04: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (1/2)

Table 05: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (2/2)

Table 06: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (1/2)

Table 07: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (2/2)

Table 08: CPT code for Actinic Keratosis Treatment (1/4)

Table 09: CPT code for Actinic Keratosis Treatment (2/4)

Table 10: CPT code for Actinic Keratosis Treatment (3/4)

Table 11: CPT code for Actinic Keratosis Treatment (4/4)

Table 12: HCPCS code for Actinic Keratosis Treatment

Table 13: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 14: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Table 15: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type

Table 16: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 17: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 18: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Table 19: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type

Table 20: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 21: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 22: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Table 23: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type

Table 24: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 25: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 26: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Table 27: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type

Table 28: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 29: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 30: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Table 31: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type

Table 32: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 33: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Table 34: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type

Table 35: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 36: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country

Table 37: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Table 38: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type

Table 39: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User

Table 40: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Region 

Table 41: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Treatment Type 

Table 42: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Disease Type 

Table 43: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By End User 

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 02: Prevalence Of Actinic Keratosis Among Male in Different Degree of Latitude

Figure 03: Prevalence Of Actinic Keratosis Among Female in Different Degree of Latitude

Figure 04: Global Dermatology Market Overview

Figure 05: Payer Mix Analysis – U.S.

Figure 06: Photo Dynamic Therapy Per Session Cost (US$), By Region (2021)

Figure 07: Chemical Peel Procedure Per Session Cost (US$), By Region (2021)

Figure 08: Cryotherapy Procedure Cost (US$), By Region (2021)

Figure 09: Topical Treatment Cost (US$), By Region (2021)

Figure 10: North America Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)

Figure 11 : North America Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)

Figure 12: North America Actinic Keratosis Treatment Market Value Share By End User (2022 E)

Figure 13: North America Actinic Keratosis Treatment Market Value Share By Country (2022 E)

Figure 14: North America Actinic Keratosis Treatment Market Value Analysis

Figure 15: North America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 16: U.S. Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 17: U.S. Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 18: Canada Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 19: Canada Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 20: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Figure 21: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 22: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 23: North America Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 24: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028

Figure 25 : Latin America Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)

Figure 26: Latin America Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)

Figure 27: Latin America Actinic Keratosis Treatment Market Value Share By End User (2022 E)

Figure 28: Latin America Actinic Keratosis Treatment Market Value Share By Country (2022 E)

Figure 29: Latin America Actinic Keratosis Treatment Market Value Analysis

Figure 30: Latin America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 31: Brazil Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 32: Brazil Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 33: Mexico Actinic Keratosis Treatment Market Value Analysis (US$ Mn),  2013–2021

Figure 34: Mexico Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 35: Rest of Latin America Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 36: Rest of Latin America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 37: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Figure 38: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 39: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 40: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 41: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028

Figure 42: Western Europe Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)

Figure 43: Western Europe Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)

Figure 44: Western Europe Actinic Keratosis Treatment Market Value Share By End User (2022 E)

Figure 45: Western Europe Actinic Keratosis Treatment Market Value Share By Country (2022 E)

Figure 46: Western Europe Actinic Keratosis Treatment Market Value Analysis

Figure 47: Western Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 48: U.K. Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 49: U.K. Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 50: Germany Actinic Keratosis Treatment Market Value Analysis (US$ Mn),

Figure 51: Germany Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 52: France Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 53: France Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 54: Italy  Actinic Keratosis Treatment Market Value Analysis (US$ Mn),

Figure 55: Italy Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 56: Spain Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 57: Spain Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 58: Rest of Western Europe Actinic Keratosis Treatment Market Value Analysis (US$ Mn),

Figure 59: Rest of Western Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 60: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Figure 61: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 62: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 63: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 64: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028

Figure 65: Eastern Europe Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)

Figure 66: Eastern Europe Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)

Figure 67: Eastern Europe Actinic Keratosis Treatment Market Value Share By End User (2022 E)

Figure 68: Eastern Europe Actinic Keratosis Treatment Market Value Share By Country (2022 E)

Figure 69: Eastern Europe Actinic Keratosis Treatment Market Value Analysis

Figure 70: Eastern Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 71: Russia Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 72: Russia Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 73: Poland Actinic Keratosis Treatment Market Value Analysis (US$ Mn),  2013–2021

Figure 74: Poland Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 75: Rest of Eastern Europe Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 76: Rest of Eastern Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 77: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Figure 78: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 79: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 80: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 81: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028

Figure 82: APEJ Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)

Figure 83: APEJ Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)

Figure 84: APEJ Actinic Keratosis Treatment Market Value Share By End User (2022 E)

Figure 85: APEJ Actinic Keratosis Treatment Market Value Share By Country (2022 E)

Figure 86: APEJ Actinic Keratosis Treatment Market Value Analysis

Figure 87: APEJ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 88: India Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 89: India Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 90: Australia & NZ Actinic Keratosis Treatment Market Value Analysis (US$ Mn),

Figure 91: Australia & NZ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 92: China Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 93: China Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 94: ASEAN Actinic Keratosis Treatment Market Value Analysis (US$ Mn),

Figure 95: ASEAN Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 96: Rest of APEJ Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 97: Rest of APEJ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 98: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Figure 99: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 100: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 101: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 102: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028

Figure 103: Japan Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)

Figure 104: Japan Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)

Figure 105: Japan Actinic Keratosis Treatment Market Value Share By End User  (2022 E)

Figure 106: Japan Actinic Keratosis Treatment Market Value Analysis

Figure 107: Japan Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 108: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Figure 109: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 110: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 111: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 112: MEA Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)

Figure 113: MEA Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)

Figure 114: MEA Actinic Keratosis Treatment Market Value Share By End User (2022 E)

Figure 115: MEA Actinic Keratosis Treatment Market Value Share By Country (2022 E)

Figure 116: MEA Actinic Keratosis Treatment Market Value Analysis

Figure 117: MEA Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 118: South Africa Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 119: South Africa Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 120: GCC Countries Actinic Keratosis Treatment Market Value Analysis (US$ Mn),

Figure 121: GCC Countries Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 122: Rest of MEA  Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 123: Rest of MEA Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028

Figure 124: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type

Figure 125: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 126: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 127: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 128: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028

Figure 129: Global Photodynamic Therapy Market: Brand Share Analysis Share Analysis (2021)

Figure 130: Global Actinic Keratosis Treatment Market Share Analysis (%), By Region, 2022 & 2028

Figure 131: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Region, 2022–2028

Figure 132: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Region, 2022–2028

Figure 133: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Region, 2022–2028

Figure 134: Global Actinic Keratosis Treatment Market Share Analysis (%), By Treatment Type, 2022 & 2028

Figure 135: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Treatment Type, 2022–2028

Figure 136: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028

Figure 137: Global Actinic Keratosis Treatment Market Share Analysis (%), By Disease Type, 2022 & 2028

Figure 138: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Disease Type, 2022–2028

Figure 139: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028

Figure 140: Global Actinic Keratosis Treatment Market Share Analysis (%), By End User, 2022 & 2028

Figure 141: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By End User, 2022–2028

Figure 142: Global Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028

Figure 143: Global Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021

Figure 144: Global Actinic Keratosis Treatment Market Value Forecast (US$ Mn),

Figure 145: Global Actinic Keratosis Treatment Market Absolute $ Opportunity, 2022–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Dermatology Lasers Market

Published : October 2020

Healthcare

Dermal Fillers Market

Published : February 2021

Healthcare

Dermal Fillers and Botulinum Toxin Market

Published : August 2017

Healthcare

Dermatology Devices Market

Published : November 2016

Google translate

Actinic Keratosis Treatment Market